NASDAQ:NEPT - Neptune Wellness Solutions Stock Price, Forecast & News

Neptune Wellness Solutions trades on the NASDAQ under the ticker symbol "NEPT."

Neptune Wellness Solutions Inc (NASDAQ:NEPT) released its quarterly earnings results on Wednesday, October, 12th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The biotechnology company earned $8.91 million during the quarter. Neptune Wellness Solutions had a negative return on equity of 39.61% and a negative net margin of 187.60%. View Neptune Wellness Solutions' Earnings History.

Neptune Wellness Solutions is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Neptune Wellness Solutions.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neptune Wellness Solutions in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Neptune Wellness Solutions.

Headlines about NEPT stock have been trending extremely negative recently, according to InfoTrie Sentiment. The research group identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Neptune Wellness Solutions earned a media sentiment score of -5.0 on InfoTrie's scale. They also gave headlines about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Neptune Wellness Solutions.

Neptune Wellness Solutions saw a increase in short interest during the month of October. As of October 15th, there was short interest totalling 8,700,000 shares, an increase of 13.6% from the September 15th total of 7,660,000 shares. Based on an average daily trading volume, of 856,800 shares, the short-interest ratio is currently 10.2 days. Approximately 11.0% of the shares of the company are short sold. View Neptune Wellness Solutions' Current Options Chain.

Some companies that are related to Neptune Wellness Solutions include Rocket Pharmaceuticals (RCKT), ZEALAND PHARMA/S (ZEAL), Phibro Animal Health (PAHC), ZIOPHARM Oncology (ZIOP), Vanda Pharmaceuticals (VNDA), Amphastar Pharmaceuticals (AMPH), Achillion Pharmaceuticals (ACHN), Stoke Therapeutics (STOK), Synthorx (THOR), Dova Pharmaceuticals (DOVA), Homology Medicines (FIXX), G1 Therapeutics (GTHX), CannTrust (CNTTF), TG Therapeutics (TGTX) and Eagle Pharmaceuticals (EGRX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Neptune Wellness Solutions investors own include Canopy Growth (CGC), Cronos Group (CRON), Tilray (TLRY), Aurora Cannabis (ACB), Zynerba Pharmaceuticals (ZYNE), Aphria (APHA), Cara Therapeutics (CARA), Innovative Industrial Properties (IIPR), GW Pharmaceuticals PLC- (GWPH) and New Age Beverages (NBEV).

Neptune Wellness Solutions' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Barclays PLC (0.14%), Alpine Group USVI LLC (0.06%), Penserra Capital Management LLC (0.05%), Millennium Management LLC (0.04%) and Janney Montgomery Scott LLC (0.03%).

NEPT stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC and Alpine Group USVI LLC.

NEPT stock was purchased by a variety of institutional investors in the last quarter, including Barclays PLC, Penserra Capital Management LLC and Janney Montgomery Scott LLC.

Shares of NEPT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NEPT stock can currently be purchased for approximately $2.87.

Neptune Wellness Solutions has a market capitalization of $268.63 million and generates $18.39 million in revenue each year. The biotechnology company earns $-17,670,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. Neptune Wellness Solutions employs 58 workers across the globe.View Additional Information About Neptune Wellness Solutions.

The official website for Neptune Wellness Solutions is http://www.neptunecorp.com/.

Neptune Wellness Solutions' mailing address is 545 PROMENADE DU CENTROPOLIS SUITE 100, LAVAL A8, H7T 0A3. The biotechnology company can be reached via phone at 45-0687-2262 or via email at [email protected]